Allografting in chronic myelogenous leukemia followed by immunotherapy

Graft-versus-leukemia reactions after bone marrow transplantation

1990 • 2,781 citations

Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients

1990 • 1,544 citations

Bone Marrow Transplantation for Chronic Myelogenous Leukemia in Chronic Phase

1988 • 887 citations

Marrow Transplantation for the Treatment of Chronic Myelogenous Leukemia

1986 • 566 citations

Bone Marrow Transplantation for Patients with Chronic Myeloid Leukemia

1986 • 422 citations

Bone marrow transplantation for patients with chronic myeloid leukaemia: T-cell depletion with Campath-1 reduces the incidence of graft-versus-host disease but may increase the risk of leukaemic relapse.

1986 • 298 citations

Chronic myelogenous leukemia in blast crisis

1987 • 283 citations

Marrow transplantation from unrelated donors for treatment of hematologic malignancies: effect of mismatching for one HLA locus

1993 • 234 citations

INDUCTION OF GRAFT-VERSUS-HOST DISEASE AFTER AUTOLOGOUS BONE MARROW TRANSPLANTATION

1989 • 196 citations

Unrelated donor marrow transplantation therapy for chronic myelogenous leukemia: initial experience of the National Marrow Donor Program

1993 • 193 citations

Unrelated donor marrow transplantation therapy for chronic myelogenous leukemia: initial experience of the National Marrow Donor Program

1993 • 155 citations

Donor leukocyte infusions for chronic myeloid leukemia in relapse after allogeneic bone marrow transplantation [letter]

1992 • 155 citations

Treatment of Chronic Granulocytic Leukemia with Chemoradiotherapy and Transplantation of Marrow from Identical Twins

1982 • 137 citations

Therapy for chronic myelogenous leukemia with unrelated donor bone marrow transplantation: results in 102 cases [published erratum appears in Blood 1990 Aug 1;76(3):654]

1990 • 122 citations

In vivo induction of gamma interferon and tumor necrosis factor by interleukin-2 infusion following intensive chemotherapy or autologous marrow transplantation

1989 • 122 citations

Hematologic and immunologic effects of the systemic administration of recombinant interleukin-2 after autologous bone marrow transplantation

1990 • 112 citations

Allogeneic bone marrow transplantation for acute lymphoblastic leukemia in remission: prolonged survival associated with acute graft-versus-host disease.

1987 • 107 citations

Collection, Cryopreservation and Subsequent Viability of Haemopoietic Stem Cells Intended for Treatment of Chronic Granulocytic Leukaemia in Blast‐Cell Transformation

1978 • 104 citations

Autologous blood stem cell transplantation for chronic granulocytic leukaemia in transformation: a report of 47 cases

1991 • 94 citations

Augmentation of mouse natural killer cell activity by LS 2616, a new immunomodulator.

1985 • 93 citations

Graft versus leukemia effect in man: the relapse rate of acute leukemia is lower after allogeneic than after syngeneic marrow transplantation.

1987 • 87 citations

Induction of cutaneous graft-versus-host disease by administration of cyclosporine to patients undergoing autologous bone marrow transplantation for acute myeloid leukemia [see comments]

1992 • 81 citations

Autografting for patients with chronic myeloid leukaemia in chronic phase: peripheral blood stem cells may have a finite capacity for maintaining haemopoiesis

1989 • 76 citations

The use of unrelated bone marrow donors in the treatment of patients with chronic myelogenous leukemia: experience of four marrow transplant centers.

1989 • 73 citations

Mechanism of action of the new immunomodulator LS2616 on T cell responses

1987 • 72 citations

Effects of the immunomodulator LS 2616 on growth and metastasis of the murine B16-F10 melanoma.

1986 • 71 citations

Autotransplants in chronic myelogenous leukaemia: strategies and results

1990 • 67 citations

Induction of cutaneous graft-versus-host disease by administration of cyclosporine to patients undergoing autologous bone marrow transplantation for acute myeloid leukemia [see comments]

1992 • 66 citations

Unrelated donor bone marrow transplantation therapy for chronic myelogenous leukemia

1987 • 64 citations

Therapy of chronic myelogenous leukemia with allogeneic bone marrow transplantation.

1987 • 64 citations

STIMULATION OF NK CELL, T CELL, AND MONOCYTE FUNCTIONS BY THE NOVEL IMMUNOMODULATOR LINOMIDE AFTER AUTOLOGOUS BONE MARROW TRANSPLANTATION

1992 • 64 citations

Therapy of Acute-Phase Chronic Myelogenous Leukemia with Intensive Chemotherapy, Blood Cell Autotransplantation and Cyclosporine A

1992 • 61 citations

Effects of the novel immunomodulator LS 2616 on the delayed-type hypersensitivity reaction to Bordetella pertussis in the rat

1986 • 50 citations

Effects of the immunomodulator LS 2616 on lymphocyte subpopulations in murine Coxsackievirus B3 myocarditis.

1989 • 49 citations

Regulation of natural killer progenitors. Studies with a novel immunomodulator with distinct effects at the precursor level.

1990 • 47 citations

Unrelated-donor bone marrow transplantation for Philadelphia chromosome-positive chronic myelogenous leukemia in children.

1993 • 42 citations

Cyclosporine-induced graft-versus-host disease following autologous bone marrow transplantation in acute myeloid leukaemia.

1990 • 36 citations

Intensive combination chemotherapy and autologous bone marrow transplantation leads to the reappearance of philadelphia chromosome-negative cells in chronic myelogenous leukemia

1991 • 34 citations

Bone marrow transplantation: Current controversies

1990 • 33 citations

Immune responses to chronic myeloid leukaemia.

1992 • 31 citations

Bone marrow transplantation for chronic granulocytic leukemia

1986 • 30 citations

Treatment of Minimal Residual Diseasein Myeloid Leukemia—The Immunotherapeutic Options with Emphasis on Linomide

1993 • 16 citations

Marrow transplantation for stable-phase chronic granulocytic leukemia.

1984 • 11 citations

Natural killer cell immunodeficiency in patients with chronic myelogenous leukemia. IV. Interleukin-1 deficiency, gamma-interferon deficiency and the restorative effects of short-term culture in the presence of interleukin-2 on natural killer cytotoxicity, natural killer-target binding and production of natural killer cytotoxic factor.

1991 • 10 citations

Therapy of chronic myelogenous leukemia with bone marrow transplantation

1990 • 9 citations

Prophylaxis and treatment of experimental tumors with the immunomodulator LS 2616

1985 • 8 citations

Treatment of minimal residual disease in acute leukemia--focus on immunotherapeutic options.

1992 • 7 citations

New Directions in the Biology and Therapy of Chronic Myeloid Leukemia

1992 • 6 citations